The principal objective of these studies is to investigate the potential role of astrocytes in the pathogenesis of hepatic encephalopathy (HE). Since the primary morphological change in HE is characterized by astrocytic degeneration, a derangement in astroglia may be a contributing factor to the development of encephalopathy. Given that astrocytes possess membrane receptors which influence glial function, as well as provide the chief mechanism for neuronal-glial communication, we propose that encephalopathy results from a toxin-induced breakdown in glial-neuronal interaction. Accordingly, we plan to investigate the potential involvement of astrocytic receptors and their second messenger' systems (cAMP, inositol phosphate) in primary astrocyte cultures. The effect of toxins implicated in HE (ammonia, short-chain fatty acids, mercaptans, phenol), their possible synergism and the effects of serum from patients with HE, on the affinity (Kd) and number (Bmax) of receptors will be determined. We have chosen to study the adrenergic, benzodiazepine, serotonin and histamine receptors, as there is evidence of their specific involvement in HE. These experiments will consist of saturation studies of specific ligands for each of the listed receptors. Where appropriate, the ability of the receptor to form high-agonist affinity complexes will also be examined. In addition, the effect of toxin exposure on basal and receptor agonist-stimulated levels of cAMP and inositol phosphate will be evaluated. Finally, the ability of agonists, antagonists and agents that act directly on the second messenger systems to modify toxin-induced changes, will be determined using light and electron microscopy. These experiments will, for the first time, delineate the effects of HE-related toxins on astrocyte receptor systems. It is anticipated that the characterization of specific receptor systems changes will elucidate possible mechanisms involved in HE and may lead to the formulation of new therapeutic strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK038153-02
Application #
3237383
Study Section
Pathology A Study Section (PTHA)
Project Start
1987-01-01
Project End
1990-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Miami School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
Miami
State
FL
Country
United States
Zip Code
33101
Dombro, R S; Bender, A S; Norenberg, M D (2000) Association between cell swelling and glycogen content in cultured astrocytes. Int J Dev Neurosci 18:161-9
Isaacks, R E; Bender, A S; Kim, C Y et al. (1999) Effect of ammonia and methionine sulfoximine on myo-inositol transport in cultured astrocytes. Neurochem Res 24:51-9
Norenberg, M D (1998) Astroglial dysfunction in hepatic encephalopathy. Metab Brain Dis 13:319-35
Hazell, A S; Norenberg, M D (1998) Ammonia and manganese increase arginine uptake in cultured astrocytes. Neurochem Res 23:869-73
Bender, A S; Norenberg, M D (1998) Effect of benzodiazepines and neurosteroids on ammonia-induced swelling in cultured astrocytes. J Neurosci Res 54:673-80
Albrecht, J; Bender, A S; Norenberg, M D (1998) Potassium-stimulated GABA release is a chloride-dependent but sodium- and calcium-independent process in cultured astrocytes. Acta Neurobiol Exp (Wars) 58:169-75
Isaacks, R E; Bender, A S; Kim, C Y et al. (1997) Effect of osmolality and myo-inositol deprivation on the transport properties of myo-inositol in primary astrocyte cultures. Neurochem Res 22:1461-9
Hazell, A S; Itzhak, Y; Liu, H et al. (1997) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes. J Neurochem 68:2216-9
Hazell, A S; Norenberg, M D (1997) Manganese decreases glutamate uptake in cultured astrocytes. Neurochem Res 22:1443-7
Norenberg, M D; Huo, Z; Neary, J T et al. (1997) The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: relation to energy metabolism and glutamatergic neurotransmission. Glia 21:124-33

Showing the most recent 10 out of 43 publications